La cadena de opciones muestra datos clave de las opciones de acciones de Conduit Pharmaceuticals a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Conduit Pharmaceuticals..

Conduit Pharmaceuticals (NASDAQ:CDT) Bolsa, Cadena de Opciones

Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

ACTG

ALUR

BTAI

CNTA

DALN

DWTX

EVAX

FFBC

HYZN

LITM

MLYS

NVNI

PBBK

SEPN

STBX

TRUG

TWLO

Twilio sube un 18,5% tras superar expectativas de ingresos. Explora los movimientos clave del mercado previo de hoy.

Acciones de Twilio (TWLO) se disparan más de un 18%; 20 acciones que se mueven en el premercado de EE.UU.

AMPG

AREB

BHAT

BWMN

CALM

DATS

DRIO

EONR

GRFX

HOTH

JBDI

LAES

RGTI

RIME

SANA

SLDB

SVMH

XTIA

Movimientos destacados del premercado: Cal-Maine Foods sube un 3,8%, Sana Biotechnology lidera con un 220,6%.

Las acciones de Cal-Maine Foods suben un 4%; Aquí están 20 acciones que se mueven en el premercado

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals Inc

Infinitii Ai Inc

CDT Environmental Technology Investment Holdings Limited - ordinary shares

CDT Environmental Technology Investment Holdings Ltd

CDTI ADVANCED MATERIALS by CDTI Advanced Materials, Inc.

CDTi Advanced Materials Inc

Cidara Therapeutics Inc

CYCC

Cyclacel Pharmaceuticals Shares Resume Then Halt Again On Circuit Breaker, Now Up 82.5%

RBC Capital analyst Elvira Scotto reiterates Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) with a Outperform and maintains $63 price target.

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Outperform on Williams Companies, Maintains $63 Price Target

Oppenheimer analyst Michael Wiederhorn maintains Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) with a Outperform and lowers the price target from $85 to $51.

Oppenheimer Maintains Outperform on Centene, Lowers Price Target to $51

Global

Reuters Cites Brazil's Suzano Exec Saying Brazil Represents 83% Of The Total Hardwood Pulp That U.S. Imports In A Given Year, That's A Relevant Number; Suzano Itself Will Find Ways Of Selling Those Those Products To Other Markets; But The Best Outcome Obviously Is Keeping The Relationships We Have Established For Several Years In North America; It's Very Hard To Predict From Our Side What Will Come, The The Lack Of Visibility Of The Next Steps Is A Factor

RBC Capital analyst Elvira Scotto reiterates Targa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) with a Outperform and maintains $205 price target.

TRGP

RBC Capital Reiterates Outperform on Targa Resources, Maintains $205 Price Target

Oppenheimer analyst Tyler Batory maintains PulteGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) with a Outperform and raises the price target from $125 to $132.

Oppenheimer Maintains Outperform on PulteGroup, Raises Price Target to $132

KAPA

Kairos Pharma Shares Halted On Circuit Breaker To The Downside, Stock Now Up 124.8%

Mizuho analyst John Roberts maintains Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) with a Outperform and raises the price target from $52 to $59.

Mizuho Maintains Outperform on Corning, Raises Price Target to $59

RBC Capital analyst Scott Hanold reiterates Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) with a Sector Perform and maintains $45 price target.

RBC Capital Reiterates Sector Perform on Range Resources, Maintains $45 Price Target

Mizuho analyst John Roberts maintains Element Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) with a Outperform and raises the price target from $24 to $27.

Mizuho Maintains Outperform on Element Solutions, Raises Price Target to $27

Cyclacel Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 55.3%

Mizuho analyst John Roberts maintains Entegris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>) with a Outperform and raises the price target from $90 to $98.

ENTG

Mizuho Maintains Outperform on Entegris, Raises Price Target to $98

Play is rolling out now and will be available to nearly 100 million vehicles by the end of 2025
The new, lower-cost plan brings subscribers over 130 music, sports, news and talk channels in-car with limited ad interruptions, plus access to the SiriusXM app
NEW YORK, July 15, 2025 /PRNewswire/ -- SiriusXM, the leading audio entertainment company in North America, today announced the launch of SiriusXM Play, the company's first low-cost, ad-supported subscription package. Welcoming new listeners to experience the company's flagship audio service at a low monthly price of less than $7, SiriusXM Play offers access to over 130 channels with limited ads in-car and even more to discover streaming in the app, delivering a compelling subset of its signature premium, curated music, talk, and sports programming at an exceptional value. For marketers, Play expands on SiriusXM's existing talk programming ad inventory to now include the previously untapped opportunity to reach consumers within its unparalleled music channels, giving advertisers a one-of-a-kind platform to meaningfully connect in the car and out with listeners across North America.

SIRI

SiriusXM Introduces SiriusXM Play, A New Low-Cost, Ad-Supported Subscription Plan; Play Available To 100M Vehicles By End Of 2025; SiriusXM Play Priced Under $7 Monthly

RBC Capital analyst Daniel Perlin reiterates Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) with a Outperform and maintains $650 price target.

RBC Capital Reiterates Outperform on Mastercard, Maintains $650 Price Target

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) has retraced 3% and fallen below $118,000, with a &#8216;whale&#8217; identified as the potential seller triggering <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46412151/why-did-bitcoin-ethereum-xrp-dogecoin-flip-bearish-ahead-of-the-cpi-inflation-data-release">the price downturn</a>.
What Happened: On-chain data provder Lookonchain <a href="https://x.com/lookonchain/status/1945045973350187134">flagged</a> on Tuesday that a whale owning 80,009 BTC, valued at about $9.46 billion, has started liquidating his position. 
So far, 40,009 BTC was transferred to Galaxy Digital. Galaxy Digital has already deposited 6,000 BTC — $706 million — to exchanges Binance and Bybit, signaling active distribution.
The news drew strong attention on social media. 
Market commentator Nuke Capital <a href="https://x.com/NukeCapital/status/1945046174630638072">noted</a> how this move came near range lows and coincided with the CPI data release day. 
He called it a psychological play and wished the bears "good luck," as the selling might add downward pressure.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46412151/why-did-bitcoin-ethereum-xrp-dogecoin-flip-bearish-ahead-of-the-cpi-inflation-data-release">Why Did Bitcoin, Ethereum, XRP, Dogecoin Flip Bearish Ahead Of The CPI Inflation Data Release?</a>
What's Next: TheDefiVillian <a href="https://x.com/thedefivillain/status/1945053763477156222">pointed</a> out the whale is only halfway through selling. 
Historically, once large sell-offs near completion, markets often start to anticipate the end of selling pressure, triggering sharp rebounds.
This "whale dump" might be the perfect re-entry opportunity for market participants that want to get long on Bitcoin, he concluded.
Daan Crypto Trades <a href="https://x.com/DaanCrypto/status/1945073058097561729">noted</a> Bitcoin is currently at a critical support zone near $118,000, with more than $3 billion in open interest above this level, much of it likely underwater longs. 
The recent price weakness is largely due to the whale offloading part of his 80,000 BTC stack through OTC and exchanges, causing significant spot selling pressure.
This has pushed funding rates higher as leveraged longs try to counterbalance the selling. 
If prices fall further, a liquidation cascade could follow. 
But if the whale's selling slows, it may signal the end of the shakeout and pave the way for a strong recovery.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46394828/bitcoin-eth-xrp-solana-are-in-for-a-long-and-exhausting-bull-market-bernstein-predicts">Bitcoin, ETH, XRP, Solana Are In For A &#8216;Long And Exhausting Bull Market,&#8217; Bernstein Predicts</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Whale Moves 80,000 BTC — Is A $9 Billion Dump Coming?

Mizuho analyst John Roberts maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Neutral and lowers the price target from $25 to $24.

Mizuho Maintains Neutral on Olin, Lowers Price Target to $24

Integration of Capella's satellite capabilities positions IonQ to pioneer the first global space-based quantum key distribution network
IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>), a leading commercial quantum computing and networking company, today announced the completion of its acquisition of Capella Space Corporation, an American space tech company with synthetic aperture radar (SAR) and satellite solutions for government and commercial applications. The closing marks a significant step in IonQ's mission to develop the world's first space-to-space and space-to-ground satellite quantum key distribution (QKD) network, enabling quantum-secure global communications.
With the acquisition now finalized, IonQ will begin developing a space-based QKD network by integrating Capella's satellite infrastructure with its quantum technology. Once complete, this QKD network will enable secure communications that prevents encryption keys from being intercepted or copied without detection. It will also serve as a platform for additional quantum networking and sensing growth vectors. Capella customers will have access to rapid, ultra-secure SAR and remote sensing through the first quantum-enabled Earth observation platform.

IONQ

IonQ Completes Acquisition Of Capella Space; IonQ To Begin Developing Space-Based QKD Network By Integrating Capella's Satellite Infrastructure With Its Quantum Technology

Mizuho analyst John Roberts maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Outperform and raises the price target from $82 to $98.

Mizuho Maintains Outperform on Westlake, Raises Price Target to $98

PCOR

Procore Achieves FedRAMP "In Process" Designation; Listed On FedRAMP Marketplace

Mizuho analyst John Roberts maintains Tronox Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) with a Neutral and lowers the price target from $6 to $5.

TROX

Mizuho Maintains Neutral on Tronox Holdings, Lowers Price Target to $5

Legal

Press Releases

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Conduit Pharmaceuticals Announces Leadership Changes

General

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Health Care

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

Contracts

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Comments

Conduit Pharmaceuticals

Conduit Pharmaceuticals (CDT) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL